60 Degrees Pharmaceuticals, Inc. (SXTP) earnings
SXTP earnings moved a median of -0.38% by the close. Quarterly and annual SXTP reports and results, each read against the price at its own news timestamp. Back to the SXTP overview →
22 measured SXTP earnings events.
Where these SXTP earnings landedvs 20 measured SXTP earnings reactions
| Middle 50% of SXTP earnings reactions | -2.32% to +2.28% |
|---|---|
| Median reaction (to close) | -0.38% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 SXTP earnings events with a measured close landed between -2.32% and +2.28%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results | Press release | +4.24% | +1.27% | |
| Form 10-Q 60 DEGREES PHARMACEUTICA For: Jun 30 | SEC filing · Form 10-Q | -0.43% | +2.14% | |
| 60 Degrees Pharmaceuticals Announces First Quarter 2026 Results | Press release | -2.03% | -6.08% | |
| Form 10-Q 60 DEGREES PHARMACEUTICA For: Mar 31 | SEC filing · Form 10-Q | -2.03% | -6.08% | |
| 60 Degrees Pharmaceuticals Announces 2025 Annual Results | Press release | -8.03% | +8.03% | |
| Form 10-K 60 DEGREES PHARMACEUTICA For: Dec 31 | SEC filing · Form 10-K | -8.03% | +8.03% | |
| 60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results | Press release | — | — | |
| Form 10-Q 60 DEGREES PHARMACEUTICA For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| 60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results | Press release | -4.17% | -0.76% | |
| Form 10-Q 60 DEGREES PHARMACEUTICA For: Jun 30 | SEC filing · Form 10-Q | — | -2.26% | |
| 60 Degrees Pharmaceuticals Announces First Quarter 2025 Results | Press release | +0.29% | +17.06% | |
| Form 10-Q 60 DEGREES PHARMACEUTICA For: Mar 31 | SEC filing · Form 10-Q | +0.93% | +0.00% | |
| 60 Degrees Pharmaceuticals Announces 2024 Annual Results | Press release | +0.00% | +1.10% | |
| Form 10-K 60 DEGREES PHARMACEUTICA For: Dec 31 | SEC filing · Form 10-K | +0.00% | +1.10% | |
| 60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results | Press release | +3.95% | -1.25% | |
| Form 10-Q 60 DEGREES PHARMACEUTICA For: Sep 30 | SEC filing · Form 10-Q | — | -1.25% | |
| 60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results | Press release | -0.39% | +2.70% | |
| Form 10-Q 60 DEGREES PHARMACEUTICA For: Jun 30 | SEC filing · Form 10-Q | — | +5.50% | |
| 60 Degrees Pharmaceuticals Announces First Quarter 2024 Results | Press release | -0.27% | -2.52% | |
| Form 10-Q 60 DEGREES PHARMACEUTICA For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -6.94% | |
| Form 10-K 60 DEGREES PHARMACEUTICA For: Dec 31 | SEC filing · Form 10-K | — | -2.79% | |
| Form 10-Q 60 DEGREES PHARMACEUTICA For: Sep 30 | SEC filing · Form 10-Q | — | -1.31% |
Keep exploring
More SXTP: analyst actions → · SEC filings → · SXTP overview →